{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:09:42Z","timestamp":1778692182902,"version":"3.51.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001091","name":"George S. and Dolores Dore Eccles Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00204-019-02430-9","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T04:18:02Z","timestamp":1552364282000},"page":"1349-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity"],"prefix":"10.1007","volume":"93","author":[{"given":"Dorina","family":"Diekj\u00fcrgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-7286","authenticated-orcid":false,"given":"David W.","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"9","key":"2430_CR1","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1128\/AAC.00280-12","volume":"56","author":"K Abdelraouf","year":"2012","unstructured":"Abdelraouf K, Braggs KH, Yin T, Truong LD, Hu M, Tam VH (2012) Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother 56(9):4625\u20134629. \n                    https:\/\/doi.org\/10.1128\/AAC.00280-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2430_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1681\/ASN.2015010060","volume":"27","author":"M Adler","year":"2016","unstructured":"Adler M, Ramm S, Hafner M et al (2016) A quantitative approach to screen for nephrotoxic compounds in vitro. J Am Soc Nephrol 27(4):1015\u20131028. \n                    https:\/\/doi.org\/10.1681\/ASN.2015010060","journal-title":"J Am Soc Nephrol"},{"key":"2430_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.02.008","author":"A Astashkina","year":"2014","unstructured":"Astashkina A, Grainger DW (2014) Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments. Adv Drug Deliv Rev. \n                    https:\/\/doi.org\/10.1016\/j.addr.2014.02.008","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2430_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.01.001","volume":"134","author":"A Astashkina","year":"2012","unstructured":"Astashkina A, Mann B, Grainger DW (2012a) A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther 134(1):82\u2013106. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2012.01.001","journal-title":"Pharmacol Ther"},{"issue":"18","key":"2430_CR5","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1016\/j.biomaterials.2012.02.063","volume":"33","author":"AI Astashkina","year":"2012","unstructured":"Astashkina AI, Mann BK, Prestwich GD, Grainger DW (2012b) A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays. Biomaterials 33(18):4700\u20134711. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2012.02.063","journal-title":"Biomaterials"},{"issue":"18","key":"2430_CR6","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1016\/j.biomaterials.2012.03.001","volume":"33","author":"AI Astashkina","year":"2012","unstructured":"Astashkina AI, Mann BK, Prestwich GD, Grainger DW (2012c) Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines. Biomaterials 33(18):4712\u20134721. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2012.03.001","journal-title":"Biomaterials"},{"issue":"24","key":"2430_CR7","doi-asserted-by":"publisher","first-page":"6323","DOI":"10.1016\/j.biomaterials.2014.04.060","volume":"35","author":"AI Astashkina","year":"2014","unstructured":"Astashkina AI, Jones CF, Thiagarajan G et al (2014) Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model. Biomaterials 35(24):6323\u20136331. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.060","journal-title":"Biomaterials"},{"issue":"7","key":"2430_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1387\/ijdb.052072hb","volume":"50","author":"H Baharvand","year":"2006","unstructured":"Baharvand H, Hashemi SM, Ashtian SK, Farrokhi A (2006) Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50(7):645\u2013652. \n                    https:\/\/doi.org\/10.1387\/ijdb.052072hb","journal-title":"Int J Dev Biol"},{"issue":"3","key":"2430_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2012.07.010","volume":"74","author":"PJ Bergen","year":"2012","unstructured":"Bergen PJ, Landersdorfer CB, Zhang J et al (2012) Pharmacokinetics and pharmacodynamics of \u2018old\u2019 polymyxins: what is new? Diagn Microbiol Infect Dis 74(3):213\u2013223. \n                    https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.07.010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"2430_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20110162","volume":"435","author":"MD Brand","year":"2011","unstructured":"Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435(2):297\u2013312. \n                    https:\/\/doi.org\/10.1042\/BJ20110162","journal-title":"Biochem J"},{"issue":"3","key":"2430_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.taap.2008.09.018","volume":"233","author":"CD Brown","year":"2008","unstructured":"Brown CD, Sayer R, Windass AS et al (2008) Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol Appl Pharmacol 233(3):428\u2013438. \n                    https:\/\/doi.org\/10.1016\/j.taap.2008.09.018","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2430_CR12","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","volume":"275","author":"SH Cha","year":"2000","unstructured":"Cha SH, Sekine T, Kusuhara H et al (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275(6):4507\u20134512","journal-title":"J Biol Chem"},{"key":"2430_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2016.12.001","author":"JK Chuah","year":"2016","unstructured":"Chuah JK, Zink D (2016) Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications. Biotechnol Adv. \n                    https:\/\/doi.org\/10.1016\/j.biotechadv.2016.12.001","journal-title":"Biotechnol Adv"},{"issue":"6","key":"2430_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","volume":"167","author":"G Ciarimboli","year":"2005","unstructured":"Ciarimboli G, Ludwig T, Lang D et al (2005) Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. Am J Pathol 167(6):1477\u20131484","journal-title":"Am J Pathol"},{"issue":"3","key":"2430_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","volume":"176","author":"G Ciarimboli","year":"2010","unstructured":"Ciarimboli G, Deuster D, Knief A et al (2010) Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol 176(3):1169\u20131180. \n                    https:\/\/doi.org\/10.2353\/ajpath.2010.090610","journal-title":"Am J Pathol"},{"issue":"10","key":"2430_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1023\/A:1003893218761","volume":"31","author":"E Crivellato","year":"1999","unstructured":"Crivellato E, Candussio L, Rosati AM, Decorti G, Klugmann FB, Mallardi F (1999) Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport. Histochem J 31(10):635\u2013643 doi. \n                    https:\/\/doi.org\/10.1023\/A:1003893218761","journal-title":"Histochem J"},{"issue":"4","key":"2430_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/0091270011400414","volume":"52","author":"M Cutler","year":"2012","unstructured":"Cutler M, Urquhart B, Velenosi T et al (2012) In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol 52(4):530\u2013542","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"2430_CR18","doi-asserted-by":"publisher","first-page":"e59219","DOI":"10.1371\/journal.pone.0059219","volume":"8","author":"TM DesRochers","year":"2013","unstructured":"DesRochers TM, Suter L, Roth A, Kaplan DL (2013) Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity. PLoS One 8(3):e59219. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0059219","journal-title":"PLoS One"},{"key":"2430_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.addr.2013.12.002","volume":"69","author":"TM DesRochers","year":"2014","unstructured":"DesRochers TM, Palma E, Kaplan DL (2014) Tissue-engineered kidney disease models. Adv Drug Deliv Rev 69:67\u201380","journal-title":"Adv Drug Deliv Rev"},{"key":"2430_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biomaterials.2017.06.020","volume":"141","author":"D Diekj\u00fcrgen","year":"2017","unstructured":"Diekj\u00fcrgen D, Grainger DW (2017) Polysaccharide matrices used in 3D in vitro cell culture systems. Biomaterials 141:96\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2017.06.020","journal-title":"Biomaterials"},{"key":"2430_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-018-2150-z","author":"D Diekj\u00fcrgen","year":"2018","unstructured":"Diekj\u00fcrgen D, Grainger DW (2018) Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model. Pflug Arch Eur J Phys. \n                    https:\/\/doi.org\/10.1007\/s00424-018-2150-z","journal-title":"Pflug Arch Eur J Phys"},{"issue":"4","key":"2430_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/adt.2014.573","volume":"12","author":"R Edmondson","year":"2014","unstructured":"Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12(4):207\u2013218. \n                    https:\/\/doi.org\/10.1089\/adt.2014.573","journal-title":"Assay Drug Dev Technol"},{"key":"2430_CR23","unstructured":"European Medicines Agency (2013) Guideline on the investigation of drug interactions. \n                    http:\/\/www.emaeuropaeu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/07\/WC500129606pdf\n                    \n                  . \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2012\/07\/WC500129606.pdf\n                    \n                  . Accessed 22 Nov 2017"},{"issue":"1","key":"2430_CR24","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/cc3995","volume":"10","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Kasiakou SK (2006) Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10(1):R27. \n                    https:\/\/doi.org\/10.1186\/cc3995","journal-title":"Crit Care"},{"issue":"11","key":"2430_CR25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nchembio.1337","volume":"9","author":"M Fallahi-Sichani","year":"2013","unstructured":"Fallahi-Sichani M, Honarnejad S, Heiser LM, Gray JW, Sorger PK (2013) Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat Chem Biol 9(11):708\u2013714. \n                    https:\/\/doi.org\/10.1038\/nchembio.1337","journal-title":"Nat Chem Biol"},{"issue":"4","key":"2430_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1208\/s12248-011-9301-x","volume":"13","author":"TC Fuchs","year":"2011","unstructured":"Fuchs TC, Hewitt P (2011) Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J 13(4):615\u2013631. \n                    https:\/\/doi.org\/10.1208\/s12248-011-9301-x","journal-title":"AAPS J"},{"issue":"9","key":"2430_CR27","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1128\/AAC.00907-16","volume":"60","author":"Z Gai","year":"2016","unstructured":"Gai Z, Visentin M, Hiller C et al (2016) Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother 60(9):5573\u20135580. \n                    https:\/\/doi.org\/10.1128\/AAC.00907-16","journal-title":"Antimicrob Agents Chemother"},{"key":"2430_CR28","unstructured":"Gilead Sciences (2010) Vistide (cidofovir). In: Product information 2016"},{"issue":"7","key":"2430_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/dna.1997.16.871","volume":"16","author":"V Gorboulev","year":"1997","unstructured":"Gorboulev V, Ulzheimer JC, Akhoundova A et al (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16(7):871\u2013881","journal-title":"DNA Cell Biol"},{"issue":"6","key":"2430_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1472-8206.2008.00633.x","volume":"22","author":"S Goutelle","year":"2008","unstructured":"Goutelle S, Maurin M, Rougier F et al (2008) The Hill equation: a review of its capabilities in pharmacological modelling. Fundam Clin Pharmacol 22(6):633\u2013648. \n                    https:\/\/doi.org\/10.1111\/j.1472-8206.2008.00633.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"2430_CR31","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.1999.276.1.F122","volume":"276","author":"M Hosoyamada","year":"1999","unstructured":"Hosoyamada M, Sekine T, Kanai Y, Endou H (1999) Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol Renal Physiol 276(1):F122\u2013F128","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1\u20132","key":"2430_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drudis.2008.11.006","volume":"14","author":"BA Justice","year":"2009","unstructured":"Justice BA, Badr NA, Felder RA (2009) 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 14(1\u20132):102\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.drudis.2008.11.006","journal-title":"Drug Discov Today"},{"issue":"2","key":"2430_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/toxsci\/kft247","volume":"137","author":"ND Keirstead","year":"2014","unstructured":"Keirstead ND, Wagoner MP, Bentley P et al (2014) Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci 137(2):278\u2013291. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kft247","journal-title":"Toxicol Sci"},{"key":"2430_CR34","volume-title":"Assay guidance manual [Internet]","author":"M Kijanska","year":"2016","unstructured":"Kijanska M, Kelm J (2016) In vitro 3D spheroids and microtissues: ATP-based cell viability and toxicity assays. In: Sittampalam G, Coussens N, Brimacombe K (eds) Assay guidance manual [Internet]. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda"},{"key":"2430_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphys.2017.00123","volume":"8","author":"SM King","year":"2017","unstructured":"King SM, Higgins JW, Nino CR et al (2017) 3D proximal tubule tissues recapitulate key aspects of renal physiology to enable nephrotoxicity testing. Front Physiol 8:123. \n                    https:\/\/doi.org\/10.3389\/fphys.2017.00123","journal-title":"Front Physiol"},{"issue":"6","key":"2430_CR36","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/026119290703500610","volume":"35","author":"A Knight","year":"2007","unstructured":"Knight A (2007) Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility. ATLA Altern Lab Anim 35(6):641","journal-title":"ATLA Altern Lab Anim"},{"issue":"4","key":"2430_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/156720212803530636","volume":"9","author":"TS Lahoti","year":"2012","unstructured":"Lahoti TS, Patel D, Thekkemadom V, Beckett R, Ray SD (2012) Doxorubicin-induced in vivo nephrotoxicity involves oxidative stress-mediated multiple pro- and anti-apoptotic signaling pathways. Curr Neurovasc Res 9(4):282\u2013295","journal-title":"Curr Neurovasc Res"},{"issue":"5","key":"2430_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jbi.2005.02.008","volume":"38","author":"TA Lasko","year":"2005","unstructured":"Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L (2005) The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 38(5):404\u2013415. \n                    https:\/\/doi.org\/10.1016\/j.jbi.2005.02.008","journal-title":"J Biomed Inform"},{"issue":"1","key":"2430_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/teb.2007.0150","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J, Cuddihy MJ, Kotov NA (2008) Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev 14(1):61\u201386. \n                    https:\/\/doi.org\/10.1089\/teb.2007.0150","journal-title":"Tissue Eng Part B Rev"},{"issue":"5","key":"2430_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tiv.2005.09.016","volume":"20","author":"W Li","year":"2006","unstructured":"Li W, Lam M, Choy D, Birkeland A, Sullivan ME, Post JM (2006) Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. Toxicol In Vitro 20(5):669\u2013676. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2005.09.016","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"2430_CR41","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1039\/c3tx50042j","volume":"2","author":"Y Li","year":"2013","unstructured":"Li Y, Oo ZY, Chang SY et al (2013) An in vitro method for the prediction of renal proximal tubular toxicity in humans. Toxicol Res 2(5):352. \n                    https:\/\/doi.org\/10.1039\/c3tx50042j","journal-title":"Toxicol Res"},{"issue":"7","key":"2430_CR42","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1021\/mp400637s","volume":"11","author":"Y Li","year":"2014","unstructured":"Li Y, Kandasamy K, Chuah JK et al (2014) Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells. Mol Pharm 11(7):1982\u20131990. \n                    https:\/\/doi.org\/10.1021\/mp400637s","journal-title":"Mol Pharm"},{"issue":"1","key":"2430_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","volume":"126","author":"Z Lin","year":"2012","unstructured":"Lin Z, Will Y (2012) Evaluation of drugs with specific organ toxicities in organ-specific cell lines. Toxicol Sci 126(1):114\u2013127. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfr339","journal-title":"Toxicol Sci"},{"issue":"3","key":"2430_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0277-5379(87)90070-8","volume":"23","author":"Y Maehara","year":"1987","unstructured":"Maehara Y, Anai H, Tamada R, Sugimachi K (1987) The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. Eur J Cancer Clin Oncol 23(3):273\u2013276","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"10","key":"2430_CR45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5694\/j.1326-5377.1992.tb121517.x","volume":"156","author":"TH Mathew","year":"1992","unstructured":"Mathew TH (1992) Drug-induced renal disease. Med J Aust 156(10):724\u2013728","journal-title":"Med J Aust"},{"issue":"1","key":"2430_CR46","doi-asserted-by":"publisher","first-page":"F236","DOI":"10.1152\/ajprenal.00273.2005","volume":"291","author":"RL Miller","year":"2006","unstructured":"Miller RL, Zhang P, Chen T, Rohrwasser A, Nelson RD (2006) Automated method for the isolation of collecting ducts. Am J Physiol Renal Physiol 291(1):F236\u2013F245","journal-title":"Am J Physiol Renal Physiol"},{"key":"2430_CR47","unstructured":"Ministry of Health Labour and Welfare Japan (2014) Guideline of drug interaction studies for drug development and appropriate provision of information. \n                    http:\/\/www.pmdagojp\/files\/000206158pdf\n                    \n                  . \n                    http:\/\/www.pmda.go.jp\/files\/000206158.pdf\n                    \n                  . Accessed 22 Nov 2017"},{"issue":"11","key":"2430_CR48","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV (2015) Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 33(11):1193\u20131200. \n                    https:\/\/doi.org\/10.1038\/nbt.3392","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2430_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","volume":"15","author":"H Motohashi","year":"2013","unstructured":"Motohashi H, Inui K (2013) Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. AAPS J 15(2):581\u2013588. \n                    https:\/\/doi.org\/10.1208\/s12248-013-9465-7","journal-title":"AAPS J"},{"issue":"10","key":"2430_CR50","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/ki.2008.405","volume":"74","author":"Y Motoyoshi","year":"2008","unstructured":"Motoyoshi Y, Matsusaka T, Saito A et al (2008) Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Kidney Int 74(10):1262\u20131269","journal-title":"Kidney Int"},{"issue":"10","key":"2430_CR51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd3801","volume":"11","author":"PY Muller","year":"2012","unstructured":"Muller PY, Milton MN (2012) The determination and interpretation of the therapeutic index in drug development. Nat Rev Drug Discov 11(10):751\u2013761. \n                    https:\/\/doi.org\/10.1038\/nrd3801","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2430_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1248\/yakushi.126.327","volume":"126","author":"J Nagai","year":"2006","unstructured":"Nagai J (2006) Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy. Yakugaku Zasshi 126(5):327\u2013335. \n                    https:\/\/doi.org\/10.1248\/yakushi.126.327","journal-title":"Yakugaku Zasshi"},{"issue":"5","key":"2430_CR53","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.semcancer.2005.05.001","volume":"15","author":"CM Nelson","year":"2005","unstructured":"Nelson CM, Bissell MJ (2005) Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15(5):342\u2013352. \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2005.05.001","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2430_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bcpt.12227","volume":"115","author":"PJ O\u2019Brien","year":"2014","unstructured":"O\u2019Brien PJ (2014) High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers. Basic Clin Pharmacol Toxicol 115(1):4\u201317. \n                    https:\/\/doi.org\/10.1111\/bcpt.12227","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"2430_CR55","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","volume":"80","author":"PJ O\u2019Brien","year":"2006","unstructured":"O\u2019Brien PJ, Irwin W, Diaz D et al (2006) High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80(9):580\u2013604. \n                    https:\/\/doi.org\/10.1007\/s00204-006-0091-3","journal-title":"Arch Toxicol"},{"issue":"10","key":"2430_CR56","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni F, Reynaud EG, Stelzer EH (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8(10):839\u2013845","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2430_CR57","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","volume":"36","author":"N Pannu","year":"2008","unstructured":"Pannu N, Nadim MK (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36(4):S216\u2013S223","journal-title":"Crit Care Med"},{"issue":"1","key":"2430_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0301-4738.37595","volume":"56","author":"R Parikh","year":"2008","unstructured":"Parikh R, Mathai A, Parikh S, Sekhar GC, Thomas R (2008) Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol 56(1):45","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2430_CR59","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.vascn.2013.08.001","volume":"68","author":"M Persson","year":"2013","unstructured":"Persson M, Loye AF, Mow T, Hornberg JJ (2013) A high content screening assay to predict human drug-induced liver injury during drug discovery. J Pharmacol Toxicol Methods 68(3):302\u2013313. \n                    https:\/\/doi.org\/10.1016\/j.vascn.2013.08.001","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"2430_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00686277","volume":"35","author":"V Pinzani","year":"1994","unstructured":"Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P (1994) Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 35(1):1\u20139","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"2430_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/toxsci\/kft005","volume":"132","author":"A Pointon","year":"2013","unstructured":"Pointon A, Abi-Gerges N, Cross MJ, Sidaway JE (2013) Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity. Toxicol Sci 132(2):317\u2013326","journal-title":"Toxicol Sci"},{"issue":"2","key":"2430_CR62","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1006\/bbrc.1998.9978","volume":"255","author":"JE Race","year":"1999","unstructured":"Race JE, Grassl SM, Williams WJ, Holtzman EJ (1999) Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Co 255(2):508\u2013514","journal-title":"Biochem Biophys Res Co"},{"issue":"10","key":"2430_CR63","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1128\/AAC.00251-06","volume":"50","author":"AS Ray","year":"2006","unstructured":"Ray AS, Cihlar T, Robinson KL et al (2006) Mechanism of active renal tubular efflux of tenofovir. Antimicrob Agents Chemother 50(10):3297\u20133304","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2430_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0248-4900(92)90026-W","volume":"74","author":"L Rebelo","year":"1992","unstructured":"Rebelo L, Carmo-Fonseca M, Moura TF (1992) Redistribution of microvilli and membrane enzymes in isolated rat proximal tubule cells. Biol Cell 74(2):203\u2013209","journal-title":"Biol Cell"},{"issue":"2","key":"2430_CR65","doi-asserted-by":"publisher","first-page":"F83","DOI":"10.1152\/ajprenal.1981.240.2.F83","volume":"240","author":"B Rennick","year":"1981","unstructured":"Rennick B (1981) Renal tubule transport of organic cations. Am J Physiol Renal Physiol 240(2):F83\u2013F89","journal-title":"Am J Physiol Renal Physiol"},{"key":"2430_CR66","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1016\/j.toxlet.2014.06.508","volume":"229","author":"TL Riss","year":"2014","unstructured":"Riss TL, Valley MP, Kupcho KR et al (2014) Validation of in vitro assays to measure cytotoxicity in 3D cell cultures. Toxicol Lett 229:S145","journal-title":"Toxicol Lett"},{"issue":"1","key":"2430_CR67","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1074\/jbc.M109959200","volume":"277","author":"C Schmitz","year":"2002","unstructured":"Schmitz C, Hilpert J, Jacobsen C et al (2002) Megalin deficiency offers protection from renal aminoglycoside accumulation. J Biol Chem 277(1):618\u2013622. \n                    https:\/\/doi.org\/10.1074\/jbc.M109959200","journal-title":"J Biol Chem"},{"issue":"1","key":"2430_CR68","first-page":"254","volume":"236","author":"DW Schwertz","year":"1986","unstructured":"Schwertz DW, Kreisberg JI, Venkatachalam MA (1986) Gentamicin-induced alterations in pig kidney epithelial (LLC-PK1) cells in culture. J Pharmacol Exp Ther 236(1):254\u2013262","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2430_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-2999(01)00962-1","volume":"419","author":"M Takeda","year":"2001","unstructured":"Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H (2001) Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol 419(2):113\u2013120","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"2430_CR70","doi-asserted-by":"publisher","first-page":"F476","DOI":"10.1152\/ajprenal.00363.2006","volume":"293","author":"S Terryn","year":"2007","unstructured":"Terryn S, Jouret F, Vandenabeele F et al (2007) A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal Physiol 293(2):F476\u2013F485. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00363.2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"2430_CR71","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0196-9781(01)00503-4","volume":"22","author":"H Tsubery","year":"2001","unstructured":"Tsubery H, Ofek I, Cohen S, Fridkin M (2001) N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity. Peptides 22(10):1675\u20131681","journal-title":"Peptides"},{"key":"2430_CR72","unstructured":"US Department of Health Human Services Food Drug Administration (2006) Innovation or stagnation: challenge and opportunity on the critical path to new medical products; 2004. \n                    http:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/CriticalPathInitiative\/CriticalPathOpportunitiesReports\/ucm113411.pdf"},{"key":"2430_CR73","unstructured":"US Department of Health Human Services Food Drug Administration Center for Drug Evaluation and Research (CDER) (2012) Draft guidance\/guidance for Industry. Drug interaction studies and study design, data analysis, implications for dosing, and labeling recommendations. \n                    http:\/\/www.fdagov\/downloads\n                    \n                  . \n                    http:\/\/www.fda.gov\/downloads\n                    \n                   2017"},{"key":"2430_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.actbio.2017.05.035","volume":"57","author":"HM Weber","year":"2017","unstructured":"Weber HM, Tsurkan MV, Magno V, Freudenberg U, Werner C (2017) Heparin-based hydrogels induce human renal tubulogenesis in vitro. Acta Biomater 57:59\u201369. \n                    https:\/\/doi.org\/10.1016\/j.actbio.2017.05.035","journal-title":"Acta Biomater"},{"issue":"1","key":"2430_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.clpt.6100014","volume":"81","author":"RL Woosley","year":"2007","unstructured":"Woosley RL, Cossman J (2007) Drug development and the FDA\u2019s Critical Path Initiative. Clin Pharmacol Ther 81(1):129\u2013133. \n                    https:\/\/doi.org\/10.1038\/sj.clpt.6100014","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2430_CR76","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.tiv.2009.06.003","volume":"23","author":"Y Wu","year":"2009","unstructured":"Wu Y, Connors D, Barber L, Jayachandra S, Hanumegowda UM, Adams SP (2009) Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol In Vitro 23(6):1170\u20131178. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2009.06.003","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2430_CR77","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","volume":"105","author":"JHJ Xu","year":"2008","unstructured":"Xu JHJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D (2008) Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 105(1):97\u2013105. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfn109","journal-title":"Toxicol Sci"},{"key":"2430_CR78","doi-asserted-by":"publisher","first-page":"38353","DOI":"10.1038\/srep38353","volume":"6","author":"S Yamaguchi","year":"2016","unstructured":"Yamaguchi S, Morizane R, Homma K et al (2016) Generation of kidney tubular organoids from human pluripotent stem cells. Sci Rep 6:38353. \n                    https:\/\/doi.org\/10.1038\/srep38353","journal-title":"Sci Rep"},{"issue":"1","key":"2430_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335 \n                    https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3","journal-title":"Cancer"},{"issue":"2","key":"2430_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0273-2300(91)90004-F","volume":"14","author":"G Zbinden","year":"1991","unstructured":"Zbinden G (1991) Predictive value of animal studies in toxicology. Regul Toxicol Pharmacol 14(2):167\u2013177","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"2430_CR81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67\u201373","journal-title":"J Biomol Screen"},{"issue":"10","key":"2430_CR82","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/mc.20315","volume":"46","author":"M Zietarska","year":"2007","unstructured":"Zietarska M, Maugard CM, Filali-Mouhim A et al (2007) Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinogen 46(10):872\u2013885. \n                    https:\/\/doi.org\/10.1002\/mc.20315","journal-title":"Mol Carcinogen"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-019-02430-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:17:33Z","timestamp":1583871453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-019-02430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2430"],"URL":"https:\/\/doi.org\/10.1007\/s00204-019-02430-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest. Both authors made substantial contributions to the manuscript according to the listed criteria in the Author Guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards and study approval"}}]}}